Implementation of an Active Screening Program for SARS-CoV2 - Experience at an Academic Medical Center. WMJ 2022 Oct;121(3):235-238
Date
10/28/2022Pubmed ID
36301652Scopus ID
2-s2.0-85140858901 (requires institutional sign-in at Scopus site) 1 CitationAbstract
BACKGROUND: This study documents the experience of an academic medical center implementing SARS-CoV2 screening of asymptomatic research personnel to support the "return-to-work" initiative and donor cadavers to support in-person student education.
METHODS: Testing was performed on samples received June 1, 2020 (for the cadaver program) and July 20, 2020 (for the personnel screening program) through September 30, 2021. Data were evaluated to document the number of cases and the positivity rate.
RESULTS: Approximately 3000 specimens were tested across both programs, with an overall positivity rate of 2.5% and 3.6% in the personnel and cadaver screening programs, respectively.
DISCUSSION: This screening program serves as an example of institutional investment in the safety of its faculty, staff, and students alike to address specific needs of a global pandemic.
Author List
Udani R, Schilter KF, Hillmer RE, Petersen RA, Srinivasan S, Marchant JS, Nattinger A, Reddi HVAuthors
Ryan Edward Hillmer PhD Associate Professor in the Cell Biology Neurobiology and Anatomy department at Medical College of WisconsinKala Schilter in the CTSI department at Medical College of Wisconsin - CTSI
MESH terms used to index this publication - Major topics in bold
Academic Medical CentersCadaver
Humans
RNA, Viral
